2024 Breakthroughs in HIV Prevention and Quantum Computing
In 2024, Gilead’s lenacapavir demonstrated groundbreaking HIV prevention efficacy while Google’s quantum chip, Willow, solved a complex problem in record time, signifying major breakthroughs in both fields.
Published on April 6, 2025
In 2024, major strides were made in both healthcare and computing. Gilead’s twice-yearly injectable, lenacapavir, showcased remarkable results by demonstrating 100% efficacy in preventing HIV infections in a Phase 3 trial reported on June 20, 2024, and a 96% reduction in another pivotal study. These clinical breakthroughs offer promising new options for HIV prevention.
On the technology front, Google’s new quantum chip, Willow, marked a significant milestone. With 105 qubits and advanced error-correction methods, Willow solved a complex computational problem in just five minutes—a task that would take traditional supercomputers an unfathomable amount of time. This accomplishment, highlighted on December 9, 2024, underscores the astonishing potential of quantum computing for future applications.